Mativ Holdings beat quarterly revenue and EPS forecasts, prompting analysts to raise their price target by 35% to US$21.00. Although growth is expected to lag the industry, consensus sentiment has imp
Mativ Holdings Inc. exceeded analyst forecasts, prompting revisions to future earnings expectations despite near-term downturn concerns. Long-term outlook remains positive with robust price targets, i
Mativ Holdings reported record Q2 2026 adjusted EBITDA of $75 million and reduced net debt leverage to 3.8 times. A tornado and elevated commodity costs from the Middle East conflict are expected to n
Mativ Holdings exceeded Q2 2026 earnings expectations with $531.8 million revenue and record EBITDA, driving a 9.2% share price increase despite tornado-related sales impacts.
Mativ Holdings reported Q2 2026 earnings with EPS of $0.50, beating estimates by $0.22, and revenue of $531.80M, up 1.22% year-over-year.
Mativ Holdings reported its strongest second quarter in 2026, achieving record adjusted EBITDA and significant free cash flow. Performance was driven by strategic pricing and cost discipline across it
Mativ Holdings reported Q2 net income of $3.6 million and revenue of $360.7 million. Adjusted earnings per share came in at 50 cents after accounting for non-recurring costs and debt extinguishment.
Mativ Holdings Inc. reported Q2 2026 revenue of $531.8 million, a 1.2% year-over-year increase, with adjusted EPS of $0.50. The company also declared a quarterly cash dividend of $0.10 per share.
Mativ Holdings posted strong Q2 2026 results with $531.8 million in net sales and $3.6 million GAAP net income, reversing a prior-year loss. Record adjusted EBITDA hit $75.0 million with a new quarter
Mativ Holdings released its Q1 2026 earnings report, reporting an EPS of $1.05 that significantly beat consensus estimates despite revenue missing expectations at $8.40 billion. The company expects it
Mativ Holdings Inc. has scheduled a webcast for August 7, 2026, to discuss its second quarter 2026 financial results and business outlook.
Mativ Holdings will announce its second-quarter 2026 financial results on August 5 after market close, followed by a webcast conference call on August 6.
Mativ Holdings Inc. financial overview covers stock price, market cap, and earnings estimates, with the next report scheduled for August 12, 2026.
Mativ Holdings Inc projects next quarter revenue of $508.50M and EPS of $0.28. Price targets range from $15.50 to $21.00, benchmarked against a Chemicals industry average score of 7.31.
Mativ Holdings Inc. confirmed participation in upcoming Stifel and Deutsche Bank investor conferences in June 2026. As a global specialty materials leader, the company focuses on Filtration, Advanced
Franklin Credit Management Corporation provides detailed stock data for Mativ Holdings Inc., including trading prices, financial metrics, and dividend yields. The report covers historical performance
Mativ Holdings reported strong earnings driven by a $98 million tax benefit and offset by $15 million in unusual expenses. Analysts warn statutory profits could decline without future growth, urging i
Mativ Holdings reported Q1 2026 earnings with an EPS of $0.06, beating estimates, while revenue decreased 1.07% year-over-year to $479.6 million, missing expectations. The results were disclosed durin
Mativ Holdings reports improved gross margins and $20M underlying free cash flow covering dividends, despite high net debt risks. Analysts recommend a speculative buy contingent on successful delevera
Mativ Holdings Inc. announced its first-quarter 2026 financial results, trading under the ticker MATV. The company is categorized within the Basic Materials sector, providing key performance data for
Mativ Holdings reported a Q1 2026 EPS loss of US$0.21, reversing prior profits and sparking debate over margin sustainability despite a low P/E ratio compared to industry averages.
Mativ Holdings reported Q1 2026 EPS of $0.06, beating forecasts despite revenue shortfalls. Strong margins and cost reductions drove stock gains as executives address input cost pressures and healthca
ChemBrief